A detailed history of Causeway Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Causeway Capital Management LLC holds 750,455 shares of BMY stock, worth $42.2 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
750,455
Previous 727,352 3.18%
Holding current value
$42.2 Million
Previous $30.2 Million 28.57%
% of portfolio
1.28%
Previous 1.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $916,264 - $1.2 Million
23,103 Added 3.18%
750,455 $38.8 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $29.3 Million - $38.5 Million
727,352 New
727,352 $30.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Causeway Capital Management LLC Portfolio

Follow Causeway Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Causeway Capital Management LLC with notifications on news.